Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Novelli

Showing results (1-10 of 110) with videos related to

Pageof 11
Sort By:
Oncoimmunology|July 30, 2013
A self antigen reopens the games in pancreatic cancerPaola Cappello, Francesco Novelli
Cytokine & Growth Factor Reviews|September 29, 2004
The role of IL-12, IL-23 and IFN-gamma in immunity to virusesFrancesco Novelli, Jean-Laurent Casanova
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
Death receptor ligands in tumorsPaola Cappello, Francesco Novelli, Guido Forni, et al.
Trends in Immunology|December 29, 2005
IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytesGabriella Regis, Laura Conti, Daniela Boselli, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2022
Discovery of Targets for Cancer ImmunopreventionPaola Cappello, Sara Bulfamante, Giorgia Mandili, et al.
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
Alpha-Enolase (<i>ENO1</i>), a potential target in novel immunotherapiesPaola Cappello, Moitza Principe, Sara Bulfamante, et al.
Cancers|January 8, 2023
Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology TherapiesAnurag Kumar Srivastava, Giorgia Guadagnin, Paola Cappello, et al.
The FEBS Journal|January 26, 2011
α-Enolase: a promising therapeutic and diagnostic tumor targetMichela Capello, Sammy Ferri-Borgogno, Paola Cappello, et al.
Cells|September 27, 2024
Fighting Pancreatic Cancer with a Vaccine-Based Winning Combination: Hope or Reality?Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, et al.
Experimental Hematology & Oncology|April 19, 2013
Three are better than one: plasminogen receptors as cancer theranostic targetsPatrizia Ceruti, Moitza Principe, Michela Capello, et al.
Pageof 11

Showing results (1-10 of 110) with videos related to

Sort By:
Pageof 11
Oncoimmunology|July 30, 2013
A self antigen reopens the games in pancreatic cancerPaola Cappello, Francesco Novelli
Cytokine & Growth Factor Reviews|September 29, 2004
The role of IL-12, IL-23 and IFN-gamma in immunity to virusesFrancesco Novelli, Jean-Laurent Casanova
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 2, 2002
Death receptor ligands in tumorsPaola Cappello, Francesco Novelli, Guido Forni, et al.
Trends in Immunology|December 29, 2005
IFNgammaR2 trafficking tunes IFNgamma-STAT1 signaling in T lymphocytesGabriella Regis, Laura Conti, Daniela Boselli, et al.
Methods in Molecular Biology (Clifton, N.J.)|January 7, 2022
Discovery of Targets for Cancer ImmunopreventionPaola Cappello, Sara Bulfamante, Giorgia Mandili, et al.
Frontiers in Bioscience (Landmark Edition)|November 5, 2016
Alpha-Enolase (<i>ENO1</i>), a potential target in novel immunotherapiesPaola Cappello, Moitza Principe, Sara Bulfamante, et al.
Cancers|January 8, 2023
Post-Translational Modifications in Tumor-Associated Antigens as a Platform for Novel Immuno-Oncology TherapiesAnurag Kumar Srivastava, Giorgia Guadagnin, Paola Cappello, et al.
The FEBS Journal|January 26, 2011
α-Enolase: a promising therapeutic and diagnostic tumor targetMichela Capello, Sammy Ferri-Borgogno, Paola Cappello, et al.
Cells|September 27, 2024
Fighting Pancreatic Cancer with a Vaccine-Based Winning Combination: Hope or Reality?Silvia Brugiapaglia, Ferdinando Spagnolo, Simona Intonti, et al.
Experimental Hematology & Oncology|April 19, 2013
Three are better than one: plasminogen receptors as cancer theranostic targetsPatrizia Ceruti, Moitza Principe, Michela Capello, et al.
Pageof 11